United Therapeutics | UTHR - Equity Capital And Reserves



United Therapeutics reported $7.17B in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.


Equity Capital And Reserves Change Date
Amarin USD 473.69M 12.49M Mar/2025
Ardelyx USD 139.53M 33.76M Jun/2025
Baxter International USD 7.05B 90M Mar/2025
Bayer EUR 30.5B 2.08B Jun/2025
Biogen USD 17.63B 655.3M Jun/2025
BioMarin Pharmaceutical USD 6.03B 233.65M Jun/2025
Gilead Sciences USD 19.67B 596M Jun/2025
GlaxoSmithKline GBP 14.35B 197M Jun/2025
Halozyme Therapeutics USD 332.75M 149.52M Jun/2025
Insmed USD 1.25B 1.15B Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
J&J USD 78.11B 6.62B Mar/2025
Moderna USD 9.4B 667M Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
PTC Therapeutics USD -206546000 20.79M Jun/2025
Regeneron Pharmaceuticals USD 29.94B 551.3M Jun/2025
Sarepta Therapeutics USD 1.36B 214.66M Jun/2025
Teva Pharmaceutical Industries USD 6.83B 572M Jun/2025
United Therapeutics USD 7.17B 366.4M Jun/2025
Vertex Pharmaceuticals USD 17.18B 679.1M Jun/2025